
Conference Coverage
Latest Content

Single-Tablet Bictegravir/Lenacapavir Effective After Treatment Switch

Newly Identified RTEL1 Variant Could Broaden Genetic Landscape of Familial PF

Non-Invasive Tests Show Promise for Tracking Treatment Response in Semaglutide MASH Trial

Flow Cytometry Tracks CAR T-Cell Therapy Persistence in Aggressive LBCL

Review Highlights IGHV Testing Complexities in CLL

Shorts










Podcasts
Center on Health Equity & Access
Continuing Medical Education
All News

The causes of financial hardship among people with rheumatoid arthritis are not necessarily based on the cost of disease-modifying therapies, according to new research.

A national survey analysis suggests a link between higher Food Inflammation Index scores and metabolic liver disease.

CAR T-cell therapy achieves meaningful responses and survival gains in this aggressive CLL complication.

Diet and metabolic health may have causal effects on MS development, suggesting that a healthy weight, controlling glucose levels, and reducing red meat intake may delay or prevent onset.

Updated guidelines set lower systolic blood pressure goals, expanded risk-based treatment, and call for stronger implementation to close care gaps.

AI and digital tools are reshaping breast cancer care—from screening and trials to remote monitoring and lifestyle support.

One in 5 of the highest-revenue drugs of 2022 was exclusively approved for rare conditions, accounting for more than 7% of US pharmaceutical spending.

To ease decision making for busy oncologists, Natera integrates molecular testing into Flatiron Health's OncoEMR, streamlining workflows with the goal of improving patient outcomes.

Papillary muscle scarring has a substantial association with both cardiovascular mortality and arrhythmia.

Early measles vaccination among Texas infants surged in early 2025, likely helping reduce their risk amid the nation's largest outbreak since 2000.






























































